NIMBLE Diagnostics

🚀 Exciting Milestone Announcement!! We are thrilled to share that NIMBLE Diagnostics has received approval from Agencia Española de Medicamentos y Productos Sanitarios to commence the NIMBLE-I Trial. The first-in-human clinical trial to test our #WAEVESystem, the world's first non-invasive technology designed to detect #coronarystent defects early, with the potential to significantly enhance #heartattack prognosis. Stay tuned as we move forward with NIMBLE-I and prepare to unveil the results soon! 📊 #NIMBLE-I #medicaldevice #cardiology #angiography #startup

🚀 Revolutionizing Stent Monitoring with Microwave Resonance Technology NIMBLE Diagnostics is a groundbreaking advancement in non-invasive medical diagnostics, leveraging microwave resonance technology to monitor stent integrity. This approach uses the principles of microwave spectroscopy to detect changes in the physical and dielectric properties of stents, providing a safer, more efficient, and cost-effective method for ensuring long-term patient health. 🔬 Their Technology NIMBLE has developed a novel system that captures the electromagnetic signature of stents, enabling precise detection of fractures, diametrical collapse, and instent restenosis. This technology a non-invasive, rapid, and accurate method to assess stent performance, providing real-time data without the need for clinician interpretation. 🔍 Addressing Traditional Challenges Current stent monitoring methods, such as invasive angiography, are complex, costly, and carry inherent risks. NIMBLE’s non-invasive solution simplifies stent monitoring, offering continuous and non-ionizing monitoring for all stent types, including bioresorbable stents. 🌟 Clinical and Economic Impact - Improving Patient Outcomes: Real-time diagnostics reduce complication risks and enable prompt interventions. - Enhancing Clinical Efficiency: Eliminating complex interpretation allows clinicians to make faster, more accurate decisions. 🌐 Integration into the Patient Journey From initial diagnosis and PCI treatment to routine follow-up visits, NIMBLE’s technology ensures continuous, real-time monitoring, detecting early signs of complications and enabling timely medical intervention. 🔬 Research in Spain and the EU Originating from the Germans Trias i Pujol Research Institute, the University of Barcelona, and the Universitat Politècnica de Catalunya, NIMBLE’s team in Spain has demonstrated the potential of this technology through significant research and studies, validating its effectiveness in early detection and monitoring. 💼 Team Expertise NIMBLE Diagnostics’ team comprises leaders in medical research, engineering, and clinical practice, driving the scientific vision and technological innovation at the company. https://lnkd.in/emCRTRkc Grow Venture Partners Namarel Ventures Intempo Ventures Instituto de Salud Carlos III European Innovation Council and SMEs Executive Agency (EISMEA) Fundación ”la Caixa” Barcelona Activa Ship2B Foundation Susana Amorós Garcia de Valdecasas 🤺 Oriol Iborra Egea, PhD: CEO, driving the scientific vision. 👨🎓 Susana Amorim Lopesós, MSe: CTO, leading technological innovation. 👨🎓 Andrew Ortega-Verdaguer, MSc: COO, managing market access strategies. 👨🎓 Carolina Gálvez-Montón, PhD: CSO, specialising in preclinical models. 👩🎓

Last Monday, our CEO, Oriol Iborra Egea, was honored to deliver the commencement speech for the Innovadors program 2024-2025 by #AGAUR. Oriol shared his journey from a passionate scientist to a dynamic entrepreneur. Following the speech, he participated in a lively roundtable discussion with Tom Hockaday, exploring how his experiences can benefit the new projects within the Innovadors program. We extend our gratitude to AGAUR and Laia Arnal Arasa for this opportunity to share our experience. We remain committed to supporting and enhancing the Catalan innovation ecosystem! 😊 #Entrepreneurship #Innovation #Leadership #ScienceToBusiness #FutureLeaders #MedicalTechnology #DigitalHealth #NIMBLE #Innovation AGAUR LinkedIn: https://lnkd.in/g2J62kec

🚨 New article on NIMBLE’s website! 🚨 Check out our latest article, reviewed by Prof. Antoni Bayes-Genis on "Recovery After Heart Attack and Stent Implantation: A Comprehensive Guide." This article covers everything from recovery timelines and activity levels to diet and emotional well-being. Read it here: https://lnkd.in/grtprgnS #HeartHealth #Recovery #Cardiology #NimbleDiagnostics #Stent #MedicalDevice #Cardiology #Angiography #DiagnosticImaging #HeartHealth #Recovery #Cardiology #NimbleDiagnostics #Stent #MedicalDevice #Cardiology #Angiography #DiagnosticImaging

What an incredible weekend last week at the Curious 2024 Conference in Mainz, Germany! Our team members Naia Jiménez Polo and Pol Gómez had the opportunity to participate in inspiring talks about the future of diagnostics and healthcare and engage in lively discussions with industry leaders. We shared our vision and explored exciting collaborations that will move our mission of enhancing cardiovascular diagnosis forward! A huge thank you to the organizers and everyone who made this event possible. We're energized and ready to bring back all the insights and inspiration to continue our journey at Nimble Diagnostics. Looking forward to next year already! We appreciate the support from the European Innovation Council and SMEs Executive Agency (EISMEA) through the #HorizonEurope Programme (HORIZON-EIC-2023-ACCELERATOROPEN-01) for the support in the development of the WAEVE System.  Link to the project: https://lnkd.in/gyFYUuyj #Curious2024 #NimbleDiagnostics #Innovation #Healthcare #Networking #Success #FutureOfDiagnostics #cardiology #Nimble #EICAccelerator #EUfunding

We will be attending #LSIEurope24, Medtech's premier partnering event this September. We are grateful for this opportunity, alongside other amazing panelists, and we look forward to this event. If you're attending, make sure to connect with our CEO, Oriol Iborra Egea who will be speaking at this event. #LSIAlumni #medtech #healthtech #cardiology #stents #LSIEurope24

🙌 🏆 Enhorabona a NIMBLE Diagnostics pel seu premi a la Millor Startup de Tecnologia Mèdica de l’any per la #EIC 🔗 Troba tota la info aquí: https://lnkd.in/dNht9z8W

Exciting News from NIMBLE Diagnostics! We are thrilled to announce that NIMBLE Diagnostics has been awarded the Best MedTech Startup of the Year by the #EIC! 🏆 A few weeks ago, our CEO Oriol Iborra showcased our WAEVE System at an ePitching competition among top MedTech startups recognized by the #EIC Accelerator. This recognition further validates our mission to introduce the world's first non-invasive technology for detecting defects in coronary stents, aiming to enhance care for #cardiovascular patients. Check out the post below to learn more and stay tuned for more exciting updates coming soon! #MedTechInnovation #HealthcareTechnology #EICAccelerator #CardiovascularHealth

⚕ EIC ePitching on MedTech: breakthrough technology solutions across Europe 🇪🇺 Eight innovative technology solutions were presented at the most recent European Innovation Council (EIC) #ePitching event on #MedTech, which took place on 18 June. The event was organized as part of the EIC Ecosystem Partnerships and Co-Investment Support program, a component of the EIC’s Business Acceleration Services (BAS). The solutions pitched were from:- 🔷 AVVie, from Austria 🔷 CurifyLabs, from Finland 🔷 GO-Pen ApS, from Denmark 🔷 NIMBLE Diagnostics, from Spain 🔷 Newronika S.p.A., from Italy  🔷 Plas-Free, from Israel 🔷 POROUS, from Germany 🔷 STENTiT, from Netherlands 🏆 NIMBLE Diagnostics was selected as the top pitch of the day, with CurifyLabs coming in second. The CEOs of both companies emphasized the importance of this opportunity for their upcoming projects. 🇪🇺 For further details on each of these projects go to 👉 https://lnkd.in/eJpCn73a #EIC #BAS #Epitching #medtech #tech #medical #health #solutions #innovation #innovators European Innovation Council and SMEs Executive Agency (EISMEA) #European #projects #researchers #scientists #success #entrepreneurship #investment #funding #motivation #SMEs  

We are excited to announce that NIMBLE recently participated in creating a video featuring Oriol Iborra Egea and Susana Amorós Garcia de Valdecasas, which will introduce us as a new member of CataloniaBio & HealthTech. CataloniaBio generously provided us with this opportunity to share our journey and vision within the biomedicine and health sector. Since joining CataloniaBio & HealthTech in March 2024, we have been inspired by the collaborative spirit and innovation within this incredible network of over 200 member companies and knowledge stakeholders.   Our co-founders, Oriol Iborra Egea and Susana Amorós Garcia de Valdecasas, had the opportunity to discuss our latest advancements and insights during the filming at the CataloniaBio & HealthTech offices. This experience has further strengthened our commitment to driving progress in biopharmaceuticals, medical technologies, and digital health.   We are so grateful for this new opportunity. Stay tuned for our presentation video. We look forward to sharing more about our journey and continuing to contribute to this vibrant community!   #CataloniaBio #HealthTech #Biomedicine #MedicalTechnology #DigitalHealth #NIMBLE #Innovation